Subscribe
Models
HUGO Series 🌟
Cell Line Models
Services
Preclinical Efficacy
Resources
About Us
SD-Rag2 KO Rat
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
SD-Rag2 KO Rat
Product Name
SD-Rag2 KO Rat
Product ID
CR005
Strain Name
SD-Rag2em1/Cya
Backgroud
SD
Status
When using this mouse strain in a publication, please cite “SD-Rag2 KO Rat (Catalog CR005) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
Basic Information
Validation Data
Related Resource
Basic Information
Gene Name
Rag2
Gene Alias
--
NCBI ID
Chromosome
Chr 3 (Rat)
MGI ID
Datasheet
Strain Description
The RAG2 gene encodes a protein that, together with the RAG1 protein, forms the RAG complex, which plays a crucial role in V(D)J recombination during the maturation of B and T cells. During V(D)J recombination, the RAG complex attaches to the recombination signal sequences (RSS) on the DNA, located next to the V, D, or J segments. The RAG complex cuts the DNA between the signal sequences and the segments, allowing the segments to separate and move to different regions of the genome. This process is repeated multiple times in B and T cells, resulting in various combinations of V, D, and J segments. The resulting protein diversity provides a broader range of recognition for foreign invaders, enabling the body to combat infections effectively. RAG2 not only participates in the catalytic reaction but also regulates the reaction by controlling access to specific loci [1].
The SD-Rag2 KO rat is an immunodeficient model with the Rag2 gene knocked out, and it can be used for extensive research in oncology and immunology. Studies have shown that the absence of functional RAG2 protein can lead to severe combined immunodeficiency (SCID). The deletion of the Rag2 gene in rats results in the absence of V(D)J recombination, blocking the differentiation, development, and maturation of T cells and B cells. This manifests as severe thymic hypoplasia, with no mature T and B cells, but a compensatory increase in NK cells [2-3]. In addition, Cyagen also offers the SDRG rat (Product Number: IR1023) with a double knockout of the Il2rg and Rag2 genes. Compared to the Rag2 gene knockout rats, the Il2rg and Rag2 double knockout rats exhibit a more severe phenotype of severe combined immunodeficiency.
Reference
Schatz DG. V(D)J recombination. Immunol Rev. 2004 Aug;200:5-11.
Noto FK, Adjan-Steffey V, Tong M, Ravichandran K, Zhang W, Arey A, McClain CB, Ostertag E, Mazhar S, Sangodkar J, DiFeo A, Crawford J, Narla G, Jamling TY. Sprague Dawley Rag2-Null Rats Created from Engineered Spermatogonial Stem Cells Are Immunodeficient and Permissive to Human Xenografts. Mol Cancer Ther. 2018 Nov;17(11):2481-2489.
Liu Q, Fan C, Zhou S, Guo Y, Zuo Q, Ma J, Liu S, Wu X, Peng Z, Fan T, Guo C, Shen Y, Huang W, Li B, He Z, Wang Y. Bioluminescent imaging of vaccinia virus infection in immunocompetent and immunodeficient rats as a model for human smallpox. Sci Rep. 2015 Aug 3;5:11397.
Strain Strategy
The rat Rag2 gene is located on rat chromosome 3. Exon 3 of this gene is knocked out using gene editing technology.

Figure 1. Gene editing strategy of SD-Rag2 KO rat.
Application Area
Oncology: Used for constructing CDX and PDX tumor models and screening and evaluating antitumor drugs;
Immunology: Research on the mechanisms of immune cell development and maturation, as well as the pathogenesis of immune diseases;
Pathogenic Microbiology: Research on the mechanisms of viral and bacterial infectious diseases;
Stem Cell Biology: Research on human stem cell transplantation.
Validation Data
Related Resource
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
